A High-Content Assay to Screen for Modulators of EGFR Function

Part of the Methods in Molecular Biology book series (MIMB, volume 1360)

Abstract

Cell-based assays have the potential and advantage to identify cell-permeable modulators of kinase function, and hence provide an alternative to the conventional enzymatic activity-driven discovery approaches that rely on purified recombinant kinase catalytic domains. Here, we describe a domain-based high-content biosensor approach to study endogenous EGFR activity whereby EGF-induced receptor activation, subsequent trafficking, and internalization are imaged and quantified using time-dependent granule formation in cells. This method can readily be used to search for EGFR modulators in both chemical and RNAi screening; with potential applicability to other receptor tyrosine kinases.

Key words

RNAi siRNA Iressa Kinase Inhibitor High-content assay EGFR Cancer Drug discovery INCA2000 INCA3000 Microscopy HTS 

References

  1. 1.
    Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10:760–774PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Ciaccio MF, Wagner JP, Chuu CP et al (2010) Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat Methods 7:148–155PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Olive DM (2004) Quantitative methods for the analysis of protein phosphorylation in drug development. Expert Rev Proteomics 1:327–341CrossRefPubMedGoogle Scholar
  4. 4.
    Pennucci J, Swanson S, Kaliyaperumal A et al (2010) Multiplexed evaluation of a cell-based assay for the detection of antidrug neutralizing antibodies to panitumumab in human serum using automated fluorescent microscopy. J Biomol Screen 15:644–652CrossRefPubMedGoogle Scholar
  5. 5.
    Ghosh RN, Grove L, Lapets OA (2004) Quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase. Assay Drug Dev Technol 2:473–481CrossRefPubMedGoogle Scholar
  6. 6.
    Lanzerstorfer P, Borgmann D, Schutz G et al (2014) Quantification and kinetic analysis of Grb2-EGFR interaction on micro-patterned surfaces for the characterization of EGFR-modulating substances. PLoS One 9(3):e92151Google Scholar
  7. 7.
    Antczak C, Bermingham A, Calder P et al (2012) Domain-based biosensor assay to screen for epidermal growth factor receptor modulators in live cells. Assay Drug Dev Technol 10:24–36PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Sigma-Aldrich: EGFR biosensor cell line. http://www.sigmaaldrich.com/catalog/product/sigma/cll1097. Accessed 11 Mar 2014
  9. 9.
    Antczak C, Mahida JP, Bhinder B et al (2012) A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: Implications in drug discovery. J Biomol Screen 17:885–899PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.HTS Core FacilityMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Center for Proteomic ChemistryNovartis Institutes for Biomedical ResearchCambridgeUSA
  3. 3.Institut Pasteur KoreaBundang-gu, Seongnam-siSouth Korea

Personalised recommendations